ID   H4G1.1c2
AC   CVCL_DC26
DR   Wikidata; Q54872156
RX   PubMed=21394221;
CC   Biotechnology: Cell line developed for CAFLUX (Chemically Activated FLUorescence eXpression) bioassay. CAFLUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a EGFP gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS:0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0284 ! H4-II-E
SX   Male
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 9
//
RX   PubMed=21394221; DOI=10.1007/s11426-010-0142-8; PMCID=PMC3049243;
RA   Zhao B., Baston D.S., Khan E., Sorrentino C., Denison M.S.;
RT   "Enhancing the response of CALUX and CAFLUX cell bioassays for
RT   quantitative detection of dioxin-like compounds.";
RL   Sci. China Chem. 53:1010-1016(2010).
//